Exome Asset Management’s DexCom DXCM Stock Holding History

Exome Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,147	Closed	-$3.33M	–	61
2025 Q4	$3.33M	Buy	+50,147	New	+$3.24M	1.59%	25
2024 Q3	–	Sell	-25,928	Closed	-$2.94M	–	68
2024 Q2	$2.94M	Buy	25,928 +1,100	+4%	+$139K	2.62%	12
2024 Q1	$3.44M	Hold	24,828	–	–	2.95%	9
2023 Q4	$3.08M	Buy	+24,828	New	+$2.54M	3.05%	9

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Exome Asset Management's DXCM Position: Q1 2026 in Review

Exome Asset Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 50,147 shares — an estimated $3.33M sold.

Exome Asset Management first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $3.44M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Exome Asset Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Exome Asset Management sold 50,147 DexCom shares in Q1 2026, an estimated $3.33M.
Exome Asset Management first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
Exome Asset Management's DexCom position peaked at $3.44M in Q1 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.